REDUCE-IT: 25% Reduction in MACE With High-Dose EPA REDUCE-IT: 25% Reduction in MACE With High-Dose EPA

Top-line results of the REDUCE-IT trial show high doses of the omega-3 oil eicosapentaenoic acid reduced CV events in patients at elevated CV risk with high triglycerides.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news